Niemann-Pick Disease Types A and B: Early Signs, Diagnosis, and Emerging Treatments
Niemann‑Pick disease (NPD) is a group of rare lysosomal storage disorders caused by SMPD1 mutations (types A/B) leading to acid sphingomyelinase (ASM) deficiency, or NPC1/NPC2 mutations (type C) causing cholesterol trafficking defects.
Type A (Infantile Neurovisceral)
- Onset: 3–6 months
- Failure to thrive, hepatosplenomegaly
- Rapid neurodegeneration: hypotonia, loss of milestones, cherry‑red macula
- Death by age 2–3
Type B (Chronic Visceral)
- Onset: childhood/adolescence
- Hepatosplenomegaly, thrombocytopenia
- Pulmonary infiltration (interstitial lung disease)
- Minimal/no neurological involvement
- Survival into adulthood common
Type C (Distinct Entity)
- Variable onset (infancy to adulthood)
- Vertical supranuclear gaze palsy, ataxia, dystonia, dementia
- Hepatosplenomegaly may be mild
Diagnosis
- ASM enzyme assay (leukocytes/fibroblasts) for A/B.
- Genetic testing (SMPD1, NPC1, NPC2) confirms.
- Filipin staining (cholesterol esterification) for type C.
Management
- Supportive: nutrition, PT/OT, pulmonary care.
- Type C: Miglustat (substrate reduction therapy) slows progression.
- Enzyme replacement (olipudase alfa) approved for type B in some regions.
- Gene therapy trials ongoing.
Early diagnosis via newborn screening (expanding) enables timely intervention and family counseling.
Genetic Disorders - Related Articles
- Sickle Cell Trait (AS Genotype): Inheritance Risks, Health Effects, and Reproductive Options
- Rectal Prolapse: Symptoms, Causes & Treatment Options
- SIADH: Who's at Risk? (Lung/Heart Disease, Cancer, Infections, Certain Meds)
- Understanding Questioning Behavior in Individuals with Autism Spectrum
- Hemangiomas: Understanding Birthmarks and Vascular Lesions
- Eugenics: Exploring the History, Ethics, and Implications
- Cri du Chat Syndrome: Genetics, 5p Deletion, and Clinical Features
